Industry: Non-cellular biologics
ArunA Bio are the experts in the design and scaling of neural-derived exosomes, developing a new class of cell-free biologics and cell-mediated neural specific drug delivery systems to treat CNS and neurodegenerative disorders.
ArunA Bio has demonstrated the unique ability of exosomes to enhance the nervous system’s self-repair mechanisms through multi- modal mechanisms, leading to both structural and functional benefits in multiple preclinical models. And, ArunA’s neural-specific exosomes have unique qualities for delivering payloads to neural cells.
Company website: ArunA Bio